Endymed Ltd

TASE:ENDY Rapporto sulle azioni

Cap. di mercato: ₪41.6m

Endymed Gestione

Gestione criteri di controllo 3/4

Endymed Il CEO è Yossi Bar-On, nominato in Mar2017, e ha un mandato di 7.67 anni. la retribuzione annua totale è $ 287.00K, composta da 99.3% di stipendio e 0.7% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.53% delle azioni della società, per un valore di ₪ 218.52K. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 5.2 anni e 2.4 anni.

Informazioni chiave

Yossi Bar-On

Amministratore delegato

US$287.0k

Compenso totale

Percentuale dello stipendio del CEO99.3%
Mandato del CEO7.7yrs
Proprietà del CEO0.5%
Durata media del management5.2yrs
Durata media del Consiglio di amministrazione2.4yrs

Aggiornamenti recenti sulla gestione

Recent updates

Endymed Ltd's (TLV:ENDY) Share Price Boosted 43% But Its Business Prospects Need A Lift Too

Nov 07
Endymed Ltd's (TLV:ENDY) Share Price Boosted 43% But Its Business Prospects Need A Lift Too

Endymed Ltd's (TLV:ENDY) 25% Dip In Price Shows Sentiment Is Matching Revenues

Sep 23
Endymed Ltd's (TLV:ENDY) 25% Dip In Price Shows Sentiment Is Matching Revenues

Endymed Ltd (TLV:ENDY) Investors Are Less Pessimistic Than Expected

Aug 06
Endymed Ltd (TLV:ENDY) Investors Are Less Pessimistic Than Expected

Here's What's Concerning About Endymed's (TLV:ENDY) Returns On Capital

May 24
Here's What's Concerning About Endymed's (TLV:ENDY) Returns On Capital

Endymed Ltd's (TLV:ENDY) Share Price Not Quite Adding Up

Mar 11
Endymed Ltd's (TLV:ENDY) Share Price Not Quite Adding Up

Endymed (TLV:ENDY) Is Looking To Continue Growing Its Returns On Capital

Oct 23
Endymed (TLV:ENDY) Is Looking To Continue Growing Its Returns On Capital

We Like These Underlying Return On Capital Trends At Endymed (TLV:ENDY)

Jul 17
We Like These Underlying Return On Capital Trends At Endymed (TLV:ENDY)

Returns Are Gaining Momentum At Endymed (TLV:ENDY)

Apr 03
Returns Are Gaining Momentum At Endymed (TLV:ENDY)

Endymed's (TLV:ENDY) Returns On Capital Are Heading Higher

Nov 18
Endymed's (TLV:ENDY) Returns On Capital Are Heading Higher

We Like These Underlying Return On Capital Trends At Endymed (TLV:ENDY)

Jun 03
We Like These Underlying Return On Capital Trends At Endymed (TLV:ENDY)

Endymed (TLV:ENDY) Is Doing The Right Things To Multiply Its Share Price

Feb 13
Endymed (TLV:ENDY) Is Doing The Right Things To Multiply Its Share Price

Here's Why We Think Endymed (TLV:ENDY) Is Well Worth Watching

Nov 28
Here's Why We Think Endymed (TLV:ENDY) Is Well Worth Watching

Endymed (TLV:ENDY) Is Experiencing Growth In Returns On Capital

Oct 31
Endymed (TLV:ENDY) Is Experiencing Growth In Returns On Capital

Is Now The Time To Put Endymed (TLV:ENDY) On Your Watchlist?

Aug 29
Is Now The Time To Put Endymed (TLV:ENDY) On Your Watchlist?

Investors Will Want Endymed's (TLV:ENDY) Growth In ROCE To Persist

Aug 01
Investors Will Want Endymed's (TLV:ENDY) Growth In ROCE To Persist

We Like These Underlying Return On Capital Trends At Endymed (TLV:ENDY)

Apr 11
We Like These Underlying Return On Capital Trends At Endymed (TLV:ENDY)

Endymed Ltd's (TLV:ENDY) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Feb 15
Endymed Ltd's (TLV:ENDY) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Returns On Capital - An Important Metric For Endymed (TLV:ENDY)

Jan 10
Returns On Capital - An Important Metric For Endymed (TLV:ENDY)

Should You Use Endymed's (TLV:ENDY) Statutory Earnings To Analyse It?

Dec 14
Should You Use Endymed's (TLV:ENDY) Statutory Earnings To Analyse It?

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Yossi Bar-On rispetto agli utili di Endymed?
DataCompenso totaleStipendioGuadagni aziendali
Sep 30 2024n/an/a

-US$2m

Jun 30 2024n/an/a

-US$835k

Mar 31 2024n/an/a

-US$437k

Dec 31 2023US$287kUS$285k

US$553k

Sep 30 2023n/an/a

US$773k

Jun 30 2023n/an/a

US$998k

Mar 31 2023n/an/a

US$907k

Dec 31 2022US$328kUS$316k

US$850k

Sep 30 2022n/an/a

US$3m

Jun 30 2022n/an/a

US$4m

Mar 31 2022n/an/a

US$5m

Dec 31 2021US$434kUS$321k

US$5m

Sep 30 2021n/an/a

US$2m

Jun 30 2021n/an/a

US$2m

Mar 31 2021n/an/a

US$838k

Dec 31 2020US$268kUS$266k

US$308k

Compensazione vs Mercato: La retribuzione totale di Yossi ($USD 287.00K ) è inferiore alla media delle aziende di dimensioni simili nel mercato IL ($USD 420.33K ).

Compensazione vs guadagni: La retribuzione di Yossi è stata coerente con le performance aziendali dell'ultimo anno.


AMMINISTRATORE DELEGATO

Yossi Bar-On (56 yo)

7.7yrs

Mandato

US$287,000

Compensazione

Mr. Yossi Bar-On, CPA has been the Chief Executive Officer of Endymed Ltd. since March 22, 2017. Mr. Bar-On served as the Chief Financial Officer since July 2014 and Chief Operating Officer at Sanara Ventu...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Yossi Bar-On
Chief Executive Officer7.7yrsUS$287.00k0.53%
₪ 218.5k
Rami Aviram
Chief Financial Officer6.3yrsUS$204.00kNessun dato
Amir Ganun
Vice President of International Sales & Marketing4.3yrsUS$279.00kNessun dato
Bill Scott
President of Endymed Inc.2.6yrsUS$352.00kNessun dato
Sima Weissman
Vice President of Research & Development6yrsUS$144.00kNessun dato
Asaf Nachmanovich
Chief Operating Officer1.8yrsNessun datoNessun dato

5.2yrs

Durata media

53yo

Età media

Gestione esperta: Il team dirigenziale di ENDY è esperto e expertise (durata media dell'incarico 5.2 anni).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Gilai Dolev
Independent External Director2.3yrsNessun datoNessun dato
Ofer Zvi
Director6.8yrsNessun datoNessun dato
Tal Rubinstein
Independent External Director2.4yrsNessun datoNessun dato
Ariel Rubashkin
Independent Director3.8yrsNessun datoNessun dato
Xiu Yang
Director2yrsNessun datoNessun dato

2.4yrs

Durata media

50yo

Età media

Consiglio di amministrazione esperto: Il consiglio di amministrazione di ENDY non è considerato esperto (durata media del mandato 2.4 anni), il che suggerisce un nuovo consiglio.